Univerzita Pardubice Fakulta chemicko- technologická

Univerzita Pardubice

Zaměstnanci
|
Studenti
English

Publikace detail

Preparation of uniform hyaluronic acid nanoparticles for biomedical applications

Autoři: Matějková Nikola | Korecká Lucie | Šálek Petr | Kočková Olga | Ewa Pavlova | Bílková Zuzana

Rok: 2023

Druh publikace: ostatní - přednáška nebo poster

Strana od-do: nestránkováno

Tituly:

Jazyk	Název	Abstrakt	Klíčová slova
eng	Preparation of uniform hyaluronic acid nanoparticles for biomedical applications	Hyaluronic acid (HA) is a naturally occurring long linear polysaccharide known for its biocompatibility, biodegradability, and non-immunogenicity. Nanoparticles from hyaluronic acid have great potential as drug delivery carriers of chemotherapeutics and other biomolecules. The robustness and reproducibility of the preparation method are essential for the final use of hyaluronic acid nanoparticles (HANPs) in biomedical applications. The nanoparticles also must have a defined size and low polydispersity index. Therefore, the whole preparation process needs to be very well optimized. Here, we present four validated protocols for the preparation of hyaluronic acid nanoparticles by cross-linking of the linear HA polymer, where four different amine-containing compounds were applied: adipic acid dihydrazide (AAD), bis(3-aminopropyl)amine (BAPA), 2,2′-(ethylenedioxy)bis(ethylamine) (EDBE), and ethylenediamine (EDA). To confirm the reproducibility of the method, the nanoparticles were thoroughly characterized. By these protocols, we were able to prepare nanoparticles of size as follows: HANPs prepared with AAD at around 80 nm, HANPs-BAPA at 120 nm, and HANPs-EDBE and HANPs-EDA at around 110 nm. All with an extremely low polydispersity index (values around 0.3). Additionally, we ensured that hyaluronic acid was not fragmented during the preparation of HANPs. Our experimental data clearly showed that the mere choice of a cross-linking agent significantly affects the size, polydispersity of nanoparticles, and their potential for biomedical use. By dynamic light scattering (DLS) analysis, all nanoparticles were demonstrated as monodisperse and uniform. However, in further characterization, concretely nanoparticle tracking analysis (NTA), HANPs-BAPA, and HANPs-EDA indicated a dichotomy of the samples. Therefore, our results show the inadequacy of using the dynamic light scattering method as the only method for size assessment. The resulting nanoparticles were characterized by na	hyaluronic acid; nanoparticles; cross-linking; biomedical applications